Search clinical trials for: DW1601

Total 49 results

Daewon Pharmaceutical Co., Ltd.

Unknown

Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis

Acute Bronchitis

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

Gastritis

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Diabetes Mellitus, Type 2

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

Gastritis Acute | Gastritis Chronic

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients (2)

Gastritis Acute | Gastritis Chronic
JW Pharmaceutical

Completed

Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

Healthy Volunteers

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

Osteoarthritis | Rheumatoid Arthritis | Back Pain | Acute Upper Respiratory Tract Infection

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

Osteoarthritis | Rheumatoid Arthritis | Back Pain | Acute Upper Respiratory Tract Infection

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults

Healthy
Daewoong Pharmaceutical Co. LTD.

Completed

Pharmacokinetics and Safety Following Administration of DWP16001

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Unknown

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Unknown

Type 2 Diabetes Patients With Renal Impairment

Type2 Diabetes
Daewoong Pharmaceutical Co. LTD.

Recruiting

A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus (ENHANCE-I)

Type 2 Diabetes Mellitus

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Enrolling by invitation

The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults

Healthy Volunteers

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Unknown

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

Diabetes Mellitus, Type 2 | FDC

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

Healthy

Korea, Republic of
VitNovo, Inc.

Completed

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Taiwan
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;

Colonoscopy
Daewoong Pharmaceutical Co. LTD.

Active, not recruiting

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease

China
Daewoong Pharmaceutical Co. LTD.

Completed

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin (ENHANCE-MEXT)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Pierre Fabre Medicament

Completed

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

Drug-induced Xerostomia

Germany
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)
Larimar Therapeutics, Inc.

Enrolling by invitation

An Open Label Extension Study of CTI-1601 in Subjects With Friedreich's Ataxia (Jive)

Friedreich Ataxia

United States
Larimar Therapeutics, Inc.

Completed

A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia

Friedreich Ataxia

United States
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities

Healthy
Respivant Sciences GmbH
Respivant Sciences Inc.

Completed

Open-label Study of Inhaled RVT-1601 in Preterm Infants

Respiratory Morbidities of Prematurity (RMP)

United States
Larimar Therapeutics, Inc.
Veristat, Inc.; Metrum Research Group, LLC

Completed

Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Friedreich Ataxia

United States
Larimar Therapeutics, Inc.
Veristat, Inc.; Metrum Research Group, LLC

Completed

Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Friedreich Ataxia

United States
Respivant Sciences GmbH
Respivant Sciences Inc.

Terminated

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF (SCENIC)

Chronic Cough | IPF | Persistent Cough in IPF

United States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. (ENHANCE-M)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Not yet recruiting

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

DW6014

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

Healthy Subjects

Korea, Republic of
NYU Langone Health

Completed

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

Primary Progressive Aphasia

United States
Dong Wha Pharmaceutical Co. Ltd.

Unknown

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Advanced Breast Cancer

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

Healthy Subjects

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema

Cirrhosis

Japan
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
Dragonfly Therapeutics

Recruiting

Study of DF1001 in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States, Denmark, Netherlands, Belgium, France
Cephalon

Withdrawn

Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer
Eyenovia Inc.

Completed

Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil

Mydriasis

United States

3

Subscribe